Galectin-9 binds IgM-BCR to regulate B cell signaling

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Cao, Anh ^a   Alluqmani, Nouf ^b   Buhari, Fatima Hifza Mohammed ^b   Wasim, Laabiah ^a   Smith, Logan K ^a   Quaile, Andrew T ^b   Shannon, Michael ^c   Hakim, Zaki ^b   Furmli, Hossai ^b   Owen, Dylan M ^c   Savchenko, Alexei ^b,d   Treanor, Bebhinn ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD22 ANTIGEN; ECALECTIN; IMMUNOGLOBULIN M; LIGAND; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C; RECOMBINANT PROTEIN; GALECTIN; IMMOBILIZED PROTEIN; LGALS9 PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BINDING;

CELL; CHEMICAL BINDING; IMMUNE RESPONSE; INHIBITION; LIGAND; MOLECULAR ANALYSIS; PROTEIN; RECOMBINATION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FAR WESTERN BLOTTING; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL CULTURE; MEMBRANE MICRODOMAIN; METABOLISM;

ANIMALS; B-LYMPHOCYTES; CELLS, CULTURED; GALECTINS; IMMOBILIZED PROTEINS; IMMUNOGLOBULIN M; LEUKOCYTE COMMON ANTIGENS; MEMBRANE MICRODOMAINS; MICE, INBRED C57BL; MODELS, BIOLOGICAL; PROTEIN BINDING; RECEPTORS, ANTIGEN, B-CELL; SIALIC ACID BINDING IG-LIKE LECTIN 2; SIGNAL TRANSDUCTION;

EID: 85051657314     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-05771-8     Document Type: Article

References (70)

1. Kurosaki, T., Shinohara, H. & Baba, Y. B cell signaling and fate decision. Annu. Rev. Immunol. 28, 21–55 (2010).
2. Depoil, D. et al. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat. Immunol. 9, 63–72 (2008).
3. Choudhuri, K. & Dustin, M. L. Signaling microdomains in T cells. FEBS Lett. 584, 4823–4831 (2010).
4. Harwood, N. E. & Batista, F. D. New insights into the early molecular events underlying B cell activation. Immunity 28, 609–619 (2008).
5. Doh, J. & Irvine, D. J. Immunological synapse arrays: patterned protein surfaces that modulate immunological synapse structure formation in T cells. Proc. Natl Acad. Sci. USA 103, 5700–5705 (2006).
6. Mossman, K. D., Campi, G., Groves, J. T. & Dustin, M. L. Altered TCR signaling from geometrically repatterned immunological synapses. Science 310, 1191–1193 (2005).
7. Salaita, K. et al. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science 327, 1380–1385 (2010).
8. Lillemeier, B. F., Pfeiffer, J. R., Surviladze, Z., Wilson, B. S. & Davis, M. M. Plasma membrane-associated proteins are clustered into islands attached to the cytoskeleton. Proc. Natl Acad. Sci. USA 103, 18992–18997 (2006).
9. Mattila, P. K. et al. The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling. Immunity 38, 461–474 (2013).
10. Maity, P. C. et al. B cell antigen receptors of the IgM and IgD classes are clustered in different protein islands that are altered during B cell activation. Sci. Signal. 8, ra93 (2015).
11. Andrews, N. L. et al. Actin restricts FcepsilonRI diffusion and facilitates antigen-induced receptor immobilization. Nat. Cell Biol. 10, 955–963 (2008).
12. Treanor, B. et al. The membrane skeleton controls diffusion dynamics and signaling through the B cell receptor. Immunity 32, 187–199 (2010).
13. Charrier, C., Ehrensperger, M. V., Dahan, M., Levi, S. & Triller, A. Cytoskeleton regulation of glycine receptor number at synapses and diffusion in the plasma membrane. J. Neurosci. 26, 8502–8511 (2006).
14. Douglass, A. D. & Vale, R. D. Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells. Cell 121, 937–950 (2005).
15. Tolar, P., Hanna, J., Krueger, P. D. & Pierce, S. K. The constant region of the membrane immunoglobulin mediates B cell-receptor clustering and signaling in response to membrane antigens. Immunity 30, 44–55 (2009).
16. Yang, J. & Reth, M. Oligomeric organization of the B-cell antigen receptor on resting cells. Nature 467, 465–469 (2010).
17. Owen, D. M., Williamson, D. J., Magenau, A. & Gaus, K. Sub-resolution lipid domains exist in the plasma membrane and regulate protein diffusion and distribution. Nat. Commun. 3, 1256 (2012).
18. Brewer, C. F., Miceli, M. C. & Baum, L. G. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr. Opin. Struct. Biol. 12, 616–623 (2002).
19. Garner, O. B. & Baum, L. G. Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling. Biochem. Soc. Trans. 36, 1472–1477 (2008).
20. Lajoie, P., Goetz, J. G., Dennis, J. W. & Nabi, I. R. Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J. Cell Biol. 185, 381–385 (2009).
21. Rabinovich, G. A., Toscano, M. A., Jackson, S. S. & Vasta, G. R. Functions of cell surface galectin-glycoprotein lattices. Curr. Opin. Struct. Biol. 17, 513–520 (2007).
22. Demetriou, M., Granovsky, M., Quaggin, S. & Dennis, J. W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409, 733–739 (2001).
23. Espeli, M., Mancini, S. J. C., Breton, C., Poirier, F. & Schiff, C. Impaired B-cell development at the pre-BII-cell stage in galectin-1-deficient mice due to inefficient pre-BII/stromal cell interactions. Blood 113, 5878–5886 (2009).
24. Ungerer, C. et al. Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations. Stem Cells Dev. 23, 755–766 (2014).
25. Tureci, O., Schmitt, H., Fadle, N., Pfreundschuh, M. & Sahin, U. Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin’s disease. J. Biol. Chem. 272, 6416–6422 (1997).
26. Zhu, C. et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6, 1245–1252 (2005).
27. Seki, M. et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 127, 78–88 (2008).
28. Harwood, N. E. & Batista, F. D. Antigen presentation to B cells. F1000 Biol. Rep. 2, 87 (2010).
29. Fleire, S. J. et al. B cell ligand discrimination through a spreading and contraction response. Science 312, 738–741 (2006).
30. Bi, S., Earl, L. A., Jacobs, L. & Baum, L. G. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways. J. Biol. Chem. 283, 12248–12258 (2008).
31. Kashio, Y. et al. Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J. Immunol. 170, 3631–3636 (2003).
32. Wada, J., Ota, K., Kumar, A., Wallner, E. I. & Kanwar, Y. S. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J. Clin. Invest. 99, 2452–2461 (1997).
33. Clayton, K. L. et al. T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases. J. Immunol. 192, 782–791 (2014).
34. Wu, Y., Li, Q. & Chen, X. Z. Detecting protein-protein interactions by Far western blotting. Nat. Protoc. 2, 3278–3284 (2007).
35. Huang, B., Jones, S. A., Brandenburg, B. & Zhuang, X. Whole-cell 3D STORM reveals interactions between cellular structures with nanometer-scale resolution. Nat. Methods 5, 1047–1052 (2008).
36. Lee, J., Sengupta, P., Brzostowski, J., Lippincott-Schwartz, J. & Pierce, S. K. The nanoscale spatial organization of B-cell receptors on immunoglobulin M- and G-expressing human B-cells. Mol. Biol. Cell 28, 511–523 (2017).
37. Coltharp, C., Yang, X. & Xiao, J. Quantitative analysis of single-molecule superresolution images. Curr. Opin. Struct. Biol. 28, 112–121 (2014).
38. Griffie, J. et al. A Bayesian cluster analysis method for single-molecule localization microscopy data. Nat. Protoc. 11, 2499–2514 (2016).
39. Treanor, B., Depoil, D., Bruckbauer, A. & Batista, F. D. Dynamic cortical actin remodeling by ERM proteins controls BCR microcluster organization and integrity. J. Exp. Med. 208, 1055–1068 (2011).
40. Hermiston, M. L., Xu, Z. & Weiss, A. CD45: a critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol. 21, 107–137 (2003).
41. Shrivastava, P., Katagiri, T., Ogimoto, M., Mizuno, K. & Yakura, H. Dynamic regulation of Src-family kinases by CD45 in B cells. Blood 103, 1425–1432 (2004).
42. Muller, J. & Nitschke, L. The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease. Nat. Rev. Rheumatol. 10, 422–428 (2014).
43. Leprince, C., Draves, K. E., Geahlen, R. L., Ledbetter, J. A. & Clark, E. A. CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proc. Natl Acad. Sci. USA 90, 3236–3240 (1993).
44. Zhang, M. & Varki, A. Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis. Glycobiology 14, 939–949 (2004).
45. Doody, G. M. et al. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269, 242–244 (1995).
46. Cheng, P. C., Dykstra, M. L., Mitchell, R. N. & Pierce, S. K. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J. Exp. Med. 190, 1549–1560 (1999).
47. Eleme, K. et al. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. J. Exp. Med. 199, 1005–1010 (2004).
48. Gupta, N. et al. Quantitative proteomic analysis of B cell lipid rafts reveals that ezrin regulates antigen receptor-mediated lipid raft dynamics. Nat. Immunol. 7, 625–633 (2006).
49. Malkusch, S. et al. Coordinate-based colocalization analysis of single-molecule localization microscopy data. Histochem. Cell Biol. 137, 1–10 (2012).
50. Gasparrini, F. et al. Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling. EMBO J. 35, 258–280 (2016).
51. Garcia-Parajo, M. F., Cambi, A., Torreno-Pina, J. A., Thompson, N. & Jacobson, K. Nanoclustering as a dominant feature of plasma membrane organization. J. Cell Sci. 127, 4995–5005 (2014).
52. Torreno-Pina, J. A. et al. Enhanced receptor-clathrin interactions induced by N-glycan-mediated membrane micropatterning. Proc. Natl Acad. Sci. USA 111, 11037–11042 (2014).
53. Schamel, W. W. & Reth, M. Monomeric and oligomeric complexes of the B cell antigen receptor. Immunity 13, 5–14 (2000).
54. Freeman, S. A. et al. Toll-like receptor ligands sensitize B-cell receptor signalling by reducing actin-dependent spatial confinement of the receptor. Nat. Commun. 6, 6168 (2015).
55. Bian, X., Kim, C. & Karniadakis, G. E. 111 years of Brownian motion. Soft Matter 12, 6331–6346 (2016).
56. Pace, K. E., Lee, C., Stewart, P. L. & Baum, L. G. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J. Immunol. 163, 3801–3811 (1999).
57. Stillman, B. N. et al. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J. Immunol. 176, 778–789 (2006).
58. Symons, A., Cooper, D. N. & Barclay, A. N. Characterization of the interaction between galectin-1 and lymphocyte glycoproteins CD45 and Thy-1. Glycobiology 10, 559–563 (2000).
59. Clark, M. C. et al. Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death. Blood 120, 4635–4644 (2012).
60. Lin, J., Brown, V. K. & Justement, L. B. Regulation of basal tyrosine phosphorylation of the B cell antigen receptor complex by the protein tyrosine phosphatase, CD45. J. Immunol. 149, 3182–3190 (1992).
61. Pani, G., Siminovitch, K. A. & Paige, C. J. The motheaten mutation rescues B cell signaling and development in CD45-deficient mice. J. Exp. Med. 186, 581–588 (1997).
62. Heng, T. S. & Painter, M. W. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9, 1091–1094 (2008).
63. Gieseke, F. et al. Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation. Eur. J. Immunol. 43, 2741–2749 (2013).
64. Chagan-Yasutan, H. et al. Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection. J. Clin. Virol. 58, 635–640 (2013).
65. McSharry, B. P. et al. Human cytomegalovirus upregulates expression of the lectin galectin 9 via induction of beta interferon. J. Virol. 88, 10990–10994 (2014).
66. Tandon, R. et al. Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers. AIDS Res. Hum. Retrovir. 30, 654–664 (2014).
67. Carrasco, Y. R., Fleire, S. J., Cameron, T., Dustin, M. L. & Batista, F. D. LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation. Immunity 20, 589–599 (2004).
68. Liu, G. et al. Using ProHits to store, annotate, and analyze affinity purification-mass spectrometry (AP-MS) data. Curr. Protoc. Bioinformatics doi: 10.1002/0471250953.bi0816s39 (2012).
69. Crocker, J. C. & Grier, D. G. Methods of digital video microscopy for colloidal studies. J. Colloid Interface Sci. 179, 289–310 (1996).
70. Ovesny, M., Krizek, P., Borkovec, J., Svindrych, Z. & Hagen, G. M. ThunderSTORM: a comprehensive ImageJ plug-in for PALM and STORM data analysis and super-resolution imaging. Bioinformatics 30, 2389–2390 (2014).